AAAAAA

   
Results: 1-18 |
Results: 18
PHASE-I TRIAL OF RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN MDR1 GENE AS MARROW CHEMOPROTECTION IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION
Authors: HESDORFFER C AYELLO J WARD M KAUBISCH A VAHDAT L BALMACEDA C GARRETT T FETELL M REISS R BANK A ANTMAN K
Citation: C. Hesdorffer et al., PHASE-I TRIAL OF RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN MDR1 GENE AS MARROW CHEMOPROTECTION IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION, Journal of clinical oncology, 16(1), 1998, pp. 165-172
FEASIBILITY OF HIGH-DOSE CHEMOTHERAPY (HDC) FOLLOWED BY AUTOLOGOUS ORSTEM-CELL SUPPORT FOR RECURRENT PROGRESSIVE OLIGODENDROGLIOMA(O)/
Authors: BALMACEDA C HESDORFFER C PAPPADOUPOLOUS K SIMMONS T VAHDAT L GARRET T ANTMAN K FETELL MR
Citation: C. Balmaceda et al., FEASIBILITY OF HIGH-DOSE CHEMOTHERAPY (HDC) FOLLOWED BY AUTOLOGOUS ORSTEM-CELL SUPPORT FOR RECURRENT PROGRESSIVE OLIGODENDROGLIOMA(O)/, Neurology, 48(3), 1997, pp. 1004-1004
INTERIM ANALYSIS OF THE RISK OF SECONDARY LEUKEMIA AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR BREAST-CANCER AND POTENTIAL USE OF HUMARAANALYSIS
Authors: RELLA V GRIFFIN M NICHOLS G VAHDAT L HESDORFFER C
Citation: V. Rella et al., INTERIM ANALYSIS OF THE RISK OF SECONDARY LEUKEMIA AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR BREAST-CANCER AND POTENTIAL USE OF HUMARAANALYSIS, Blood, 90(10), 1997, pp. 4474-4474
RAPIDLY CYCLED COURSES OF HIGH-DOSE ALKYLATING-AGENTS SUPPORTED BY FILGRASTIM AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: VAHDAT L RAPTIS G FENNELLY D HAMILTON N REICH L TIERSTEN A HARRISON M HUDIS C MOORE M YAO TJ NORTON L CROWN J
Citation: L. Vahdat et al., RAPIDLY CYCLED COURSES OF HIGH-DOSE ALKYLATING-AGENTS SUPPORTED BY FILGRASTIM AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER, Clinical cancer research, 1(11), 1995, pp. 1267-1273
HIGH-DOSE CHEMOTHERAPY OF BREAST-CANCER - CURRENT STATUS AND DEVELOPMENTAL STRATEGIES
Authors: CROWN J RAPTIS G HAMILTON N FENNELLY D VAHDAT L NORTON L
Citation: J. Crown et al., HIGH-DOSE CHEMOTHERAPY OF BREAST-CANCER - CURRENT STATUS AND DEVELOPMENTAL STRATEGIES, European journal of cancer, 31A(5), 1995, pp. 809-811
CARBOPLATIN AND ETOPOSIDE IN METASTATIC BREAST-CANCER
Authors: CROWN J HAMILTON N RAPTIS G KRITZ A VAHDAT L NORTON L
Citation: J. Crown et al., CARBOPLATIN AND ETOPOSIDE IN METASTATIC BREAST-CANCER, Annals of oncology, 6(4), 1995, pp. 403-403
HIGH-DOSE CHEMOTHERAPY OF METASTATIC BREAST-CANCER - A REVIEW
Authors: VAHDAT L RAPTIS G FENNELLY D CROWN J
Citation: L. Vahdat et al., HIGH-DOSE CHEMOTHERAPY OF METASTATIC BREAST-CANCER - A REVIEW, Cancer investigation, 13(5), 1995, pp. 505-510
HIGH-DOSE THERAPY FOR BREAST-CANCER
Authors: VAHDAT L ANTMAN K
Citation: L. Vahdat et K. Antman, HIGH-DOSE THERAPY FOR BREAST-CANCER, Blood reviews, 9(3), 1995, pp. 191-200
SEVERE MOTOR WEAKNESS FROM HIGH-DOSE 2-CHLORODEOXYADENOSINE
Authors: WONG ET VAHDAT L TUNKEL RS WILE MJ ROSENBLUM M WARRELL RP FOLEY KM
Citation: Et. Wong et al., SEVERE MOTOR WEAKNESS FROM HIGH-DOSE 2-CHLORODEOXYADENOSINE, Annals of neurology, 36(2), 1994, pp. 293-293
HIGH-INTENSITY CHEMOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT
Authors: FENNELLY D VAHDAT L SCHNEIDER J REICH L HAMILTON N HAKES T RAPTIS G WASSERHEIT C KRITZ A GULATI S MARKMAN M HOSKINS W NORTON L CROWN J
Citation: D. Fennelly et al., HIGH-INTENSITY CHEMOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT, Seminars in oncology, 21(2), 1994, pp. 21-25
EARLY MORTALITY AND THE RETINOIC ACID SYNDROME IN ACUTE PROMYELOCYTICLEUKEMIA - IMPACT OF LEUKOCYTOSIS, LOW-DOSE CHEMOTHERAPY, PMN RAR-ALPHA ISOFORM, AND CD13 EXPRESSION IN PATIENTS TREATED WITH ALL-TRANS-RETINOIC ACID/
Authors: VAHDAT L MASLAK P MILLER WH EARDLEY A HELLER G SCHEINBERG DA WARRELL RP
Citation: L. Vahdat et al., EARLY MORTALITY AND THE RETINOIC ACID SYNDROME IN ACUTE PROMYELOCYTICLEUKEMIA - IMPACT OF LEUKOCYTOSIS, LOW-DOSE CHEMOTHERAPY, PMN RAR-ALPHA ISOFORM, AND CD13 EXPRESSION IN PATIENTS TREATED WITH ALL-TRANS-RETINOIC ACID/, Blood, 84(11), 1994, pp. 3843-3849
LONG-TERM HEMATOPOIESIS IS NOT AFFECTED BY RAPID-CYCLING OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (HDC) PRIOR TO FULL HEMATOLOGIC RECOVERY
Authors: TIERSTEN A RAPTIS G CROWN J VAHDAT L HAMILTON N REICH L DAMASKOS P NORTON L
Citation: A. Tiersten et al., LONG-TERM HEMATOPOIESIS IS NOT AFFECTED BY RAPID-CYCLING OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (HDC) PRIOR TO FULL HEMATOLOGIC RECOVERY, Blood, 84(10), 1994, pp. 10000210-10000210
THERAPEUTIC AND NEUROTOXIC EFFECTS OF 2-CHLORODEOXYADENOSINE IN ADULTS WITH ACUTE MYELOID-LEUKEMIA
Authors: VAHDAT L WONG ET WILE MJ ROSENBLUM M FOLEY KM WARRELL RP
Citation: L. Vahdat et al., THERAPEUTIC AND NEUROTOXIC EFFECTS OF 2-CHLORODEOXYADENOSINE IN ADULTS WITH ACUTE MYELOID-LEUKEMIA, Blood, 84(10), 1994, pp. 3429-3434
RAPID ADMINISTRATION OF MULTIPLE CYCLES OF HIGH-DOSE MYELOSUPPRESSIVECHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: CROWN J KRITZ A VAHDAT L REICH L MOORE M HAMILTON N SCHNEIDER J HARRISON M GILEWSKI T HUDIS C GULATI S NORTON L
Citation: J. Crown et al., RAPID ADMINISTRATION OF MULTIPLE CYCLES OF HIGH-DOSE MYELOSUPPRESSIVECHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1144-1149
TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA IN ADULTS WITH 2-CHLORO-DEOXYADENOSINE
Authors: VAHDAT L WARRELL RP
Citation: L. Vahdat et Rp. Warrell, TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA IN ADULTS WITH 2-CHLORO-DEOXYADENOSINE, Blood, 82(10), 1993, pp. 10000129-10000129
PERIPHERAL-BLOOD PROGENITOR SUPPORTED HIGH-DOSE CHEMOTHERAPY - DETERMINATION OF A THRESHOLD NUMBER OF CD34+ CELLS FOR RELIABLE ENGRAFTMENT
Authors: RAPTIS G VAHDAT L FENNELLY D REICH L HAMILTON N YAO TJ BENGALA C SCHNEIDER J SHAPIRO F GULATI S NORTON L CROWN J
Citation: G. Raptis et al., PERIPHERAL-BLOOD PROGENITOR SUPPORTED HIGH-DOSE CHEMOTHERAPY - DETERMINATION OF A THRESHOLD NUMBER OF CD34+ CELLS FOR RELIABLE ENGRAFTMENT, Blood, 82(10), 1993, pp. 10000289-10000289
EX-VIVO EXPANSION OF CD34(- A COMPARISON OF 20-PERCENT FETAL CALF SERUM TO VARIOUS CONCENTRATIONS OF AUTOLOGOUS PLASMA OR SERUM IN GAS-PERMEABLE BAGS() CELLS )
Authors: SHAPIRO F BENGALA C SCHNEIDER J REICH L VAHDAT L FENNELLY D RAPTIS G NORTON L HEIMFELD S BERENSON R MOORE MAS
Citation: F. Shapiro et al., EX-VIVO EXPANSION OF CD34(- A COMPARISON OF 20-PERCENT FETAL CALF SERUM TO VARIOUS CONCENTRATIONS OF AUTOLOGOUS PLASMA OR SERUM IN GAS-PERMEABLE BAGS() CELLS ), Blood, 82(10), 1993, pp. 10000491-10000491
SUPERIORITY OF HIGH-DOSE CYCLOPHOSPHAMIDE PLUS GCSF VERSUS EITHER LOWER DOSE CYCLOPHOSPHAMIDE PLUS GCSF OR GCSF ALONE IN MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS
Authors: VAHDAT L RAPTIS G FENNELLY D REICH L HAMILTON N YAO TJ NORTON L GULATI S CROWN J
Citation: L. Vahdat et al., SUPERIORITY OF HIGH-DOSE CYCLOPHOSPHAMIDE PLUS GCSF VERSUS EITHER LOWER DOSE CYCLOPHOSPHAMIDE PLUS GCSF OR GCSF ALONE IN MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS, Blood, 82(10), 1993, pp. 10000643-10000643
Risultati: 1-18 |